Vir Biotechnology Inc Sustainability Reports
Vir Biotechnology, Inc. is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases and cancer. The company develops therapeutic platforms including monoclonal antibodies, T-cell therapies, and small interfering RNA combinations.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00H2QQ8V2
3 reports from 2021 to 2024